These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

174 related articles for article (PubMed ID: 15797963)

  • 1. The type 2 deiodinase A/G (Thr92Ala) polymorphism is associated with decreased enzyme velocity and increased insulin resistance in patients with type 2 diabetes mellitus.
    Canani LH; Capp C; Dora JM; Meyer EL; Wagner MS; Harney JW; Larsen PR; Gross JL; Bianco AC; Maia AL
    J Clin Endocrinol Metab; 2005 Jun; 90(6):3472-8. PubMed ID: 15797963
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The type 2 deiodinase Thr92Ala polymorphism is associated with increased bone turnover and decreased femoral neck bone mineral density.
    Heemstra KA; Hoftijzer H; van der Deure WM; Peeters RP; Hamdy NA; Pereira A; Corssmit EP; Romijn JA; Visser TJ; Smit JW
    J Bone Miner Res; 2010 Jun; 25(6):1385-91. PubMed ID: 20200941
    [TBL] [Abstract][Full Text] [Related]  

  • 3. D2 Thr92Ala and PPARγ2 Pro12Ala polymorphisms interact in the modulation of insulin resistance in type 2 diabetic patients.
    Estivalet AA; Leiria LB; Dora JM; Rheinheimer J; Bouças AP; Maia AL; Crispim D
    Obesity (Silver Spring); 2011 Apr; 19(4):825-32. PubMed ID: 20930717
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Type 2 deiodinase Thr92Ala polymorphism is associated with disrupted placental activity but not with dysglycemia or adverse gestational outcomes: a genetic association study.
    Dora JM; Wajner SM; Costa JD; Pinto Ribeiro RV; Leiria LB; Lopes MG; Vitali da Silva A; Crispim D; Maia AL
    Fertil Steril; 2014 Mar; 101(3):833-9. PubMed ID: 24355051
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Association of the type 2 deiodinase Thr92Ala polymorphism with type 2 diabetes: case-control study and meta-analysis.
    Dora JM; Machado WE; Rheinheimer J; Crispim D; Maia AL
    Eur J Endocrinol; 2010 Sep; 163(3):427-34. PubMed ID: 20566590
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Type 2 deiodinase Thr92Ala polymorphism is not associated with arterial hypertension in type 2 diabetes mellitus patients.
    Canani LH; Leie MA; Machado WE; Capp C; Maia AL
    Hypertension; 2007 Jun; 49(6):e47; author reply e48. PubMed ID: 17389255
    [No Abstract]   [Full Text] [Related]  

  • 7. Type 2 Deiodinase Thr92Ala Polymorphism and Aging Are Associated with a Decreased Pituitary Sensitivity to Thyroid Hormone.
    Luongo C; De Stefano MA; Ambrosio R; Volpe F; Porcelli T; Golia V; Bellevicine C; Troncone G; Masone S; Damiano V; Matano E; Klain M; Schlumberger M; Salvatore D
    Thyroid; 2023 Mar; 33(3):294-300. PubMed ID: 36680751
    [No Abstract]   [Full Text] [Related]  

  • 8. The Thr92Ala deiodinase type 2 (DIO2) variant is not associated with type 2 diabetes or indices of insulin resistance in the old order of Amish.
    Mentuccia D; Thomas MJ; Coppotelli G; Reinhart LJ; Mitchell BD; Shuldiner AR; Celi FS
    Thyroid; 2005 Nov; 15(11):1223-7. PubMed ID: 16356084
    [TBL] [Abstract][Full Text] [Related]  

  • 9. FABP2 Ala54Thr polymorphism and diabetes in Chilean elders.
    Albala C; Villarroel A; Santos JL; Angel B; Lera L; Liberman C; Sanchez H; Pérez-Bravo F
    Diabetes Res Clin Pract; 2007 Aug; 77(2):245-50. PubMed ID: 17292994
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Type 2 deiodinase polymorphism (threonine 92 alanine) predicts L-thyroxine dose to achieve target thyrotropin levels in thyroidectomized patients.
    Torlontano M; Durante C; Torrente I; Crocetti U; Augello G; Ronga G; Montesano T; Travascio L; Verrienti A; Bruno R; Santini S; D'Arcangelo P; Dallapiccola B; Filetti S; Trischitta V
    J Clin Endocrinol Metab; 2008 Mar; 93(3):910-3. PubMed ID: 18073314
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The Thr92Ala 5' type 2 deiodinase gene polymorphism is associated with a delayed triiodothyronine secretion in response to the thyrotropin-releasing hormone-stimulation test: a pharmacogenomic study.
    Butler PW; Smith SM; Linderman JD; Brychta RJ; Alberobello AT; Dubaz OM; Luzon JA; Skarulis MC; Cochran CS; Wesley RA; Pucino F; Celi FS
    Thyroid; 2010 Dec; 20(12):1407-12. PubMed ID: 21054208
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Thr92Ala polymorphism in the type 2 deiodinase is not associated with T4 dose in athyroid patients or patients with Hashimoto thyroiditis.
    Heemstra KA; Hoftijzer HC; van der Deure WM; Peeters RP; Fliers E; Appelhof BC; Wiersinga WM; Corssmit EP; Visser TJ; Smit JW
    Clin Endocrinol (Oxf); 2009 Aug; 71(2):279-83. PubMed ID: 19018782
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Extracellular superoxide dismutase gene polymorphism is associated with insulin resistance and the susceptibility to type 2 diabetes.
    Tamai M; Furuta H; Kawashima H; Doi A; Hamanishi T; Shimomura H; Sakagashira S; Nishi M; Sasaki H; Sanke T; Nanjo K
    Diabetes Res Clin Pract; 2006 Feb; 71(2):140-5. PubMed ID: 15990193
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Heterozygote Advantage of the Type II Deiodinase Thr92Ala Polymorphism on Intrahospital Mortality of COVID-19.
    de Lima Beltrão FE; de Almeida Beltrão DC; Carvalhal G; de Lima Beltrão FE; de Souza Braga Filho J; de Brito Oliveira J; de Jesus JDS; Machado GJR; Dos Santos Silva H; Teixeira HMP; Rodrigues JL; de Figueiredo CAV; Dos Santos Costa R; Hecht F; Bianco AC; da Conceição Rodrigues Gonçalves M; Ramos HE
    J Clin Endocrinol Metab; 2022 May; 107(6):e2488-e2501. PubMed ID: 35137147
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The rs225017 polymorphism in the 3'UTR of the human DIO2 gene is associated with increased insulin resistance.
    Leiria LB; Dora JM; Wajner SM; Estivalet AA; Crispim D; Maia AL
    PLoS One; 2014; 9(8):e103960. PubMed ID: 25105294
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Association of Type II 5' Monodeiodinase Thr92Ala Single Nucleotide Gene Polymorphism and Circulating Thyroid Hormones Among Type 2 Diabetes Mellitus Patients.
    Yalakanti D; Dolia PB
    Indian J Clin Biochem; 2016 Apr; 31(2):152-61. PubMed ID: 27069323
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Thr92Ala polymorphism in the type 2 deiodinase gene: an evolutionary perspective.
    Ricci C; Kakularam KR; Marzocchi C; Capecchi G; Riolo G; Boschin F; Kuhn H; Castagna MG; Cantara S
    J Endocrinol Invest; 2020 Dec; 43(12):1749-1757. PubMed ID: 32436183
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The Thr92Ala polymorphism in the type 2 deiodinase gene is linked to depression in patients with COVID-19 after hospital discharge.
    Beltrão DCA; Beltrão FEL; Carvalhal G; Beltrão FLL; Brito ADS; Silva HDS; Teixeira HMP; Rodrigues JL; de Figueiredo CAV; Costa RDS; Pordeus LCM; Vieira GC; Ramos HE
    Front Endocrinol (Lausanne); 2024; 15():1366500. PubMed ID: 38911040
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Thr92Ala polymorphism of human type 2 deiodinase gene (hD2) affects the development of Graves' disease, treatment efficiency, and rate of remission.
    Alina B; Daria P; Olga F; Vladislav S; Anna K; Elena G
    Clin Dev Immunol; 2012; 2012():340542. PubMed ID: 23193417
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The type 2 deiodinase (DIO2) A/G polymorphism is not associated with glycemic traits: the Framingham Heart Study.
    Maia AL; Dupuis J; Manning A; Liu C; Meigs JB; Cupples LA; Larsen PR; Fox CS
    Thyroid; 2007 Mar; 17(3):199-202. PubMed ID: 17381351
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.